BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 37365881)

  • 1. Oral contraceptives containing drospirenone for premenstrual syndrome.
    Ma S; Song SJ
    Cochrane Database Syst Rev; 2023 Jun; 6(6):CD006586. PubMed ID: 37365881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral contraceptives containing drospirenone for premenstrual syndrome.
    Lopez LM; Kaptein AA; Helmerhorst FM
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006586. PubMed ID: 22336820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives containing drospirenone for premenstrual syndrome.
    Lopez LM; Kaptein AA; Helmerhorst FM
    Cochrane Database Syst Rev; 2009 Apr; (2):CD006586. PubMed ID: 19370644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral contraceptives containing drospirenone for premenstrual syndrome.
    Lopez LM; Kaptein A; Helmerhorst FM
    Cochrane Database Syst Rev; 2008 Jan; (1):CD006586. PubMed ID: 18254106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-contraceptive oestrogen-containing preparations for controlling symptoms of premenstrual syndrome.
    Naheed B; Kuiper JH; Uthman OA; O'Mahony F; O'Brien PM
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD010503. PubMed ID: 28257559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acupuncture and acupressure for premenstrual syndrome.
    Armour M; Ee CC; Hao J; Wilson TM; Yao SS; Smith CA
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005290. PubMed ID: 30105749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The efficiency of oral contraception containing drospirenone in treating symptoms of premenstrual syndrome or premenstrual dysphoric disorder in gyneacology practice].
    Svojanovská K
    Ceska Gynekol; 2010 Oct; 75(5):474-80. PubMed ID: 21374928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective serotonin reuptake inhibitors for premenstrual syndrome.
    Marjoribanks J; Brown J; O'Brien PM; Wyatt K
    Cochrane Database Syst Rev; 2013 Jun; 2013(6):CD001396. PubMed ID: 23744611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined oral contraceptive pill for primary dysmenorrhoea.
    Schroll JB; Black AY; Farquhar C; Chen I
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD002120. PubMed ID: 37523477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined hormonal contraceptives for heavy menstrual bleeding.
    Lethaby A; Wise MR; Weterings MA; Bofill Rodriguez M; Brown J
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD000154. PubMed ID: 30742315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifibrinolytics for heavy menstrual bleeding.
    Bryant-Smith AC; Lethaby A; Farquhar C; Hickey M
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD000249. PubMed ID: 29656433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined oral contraceptive pills for treatment of acne.
    Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
    Cochrane Database Syst Rev; 2012 Jul; (7):CD004425. PubMed ID: 22786490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combined oral contraceptive pills for treatment of acne.
    Arowojolu AO; Gallo MF; Lopez LM; Grimes DA
    Cochrane Database Syst Rev; 2012 Jun; (6):CD004425. PubMed ID: 22696343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome.
    Fraison E; Kostova E; Moran LJ; Bilal S; Ee CC; Venetis C; Costello MF
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD005552. PubMed ID: 32794179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioidentical hormones for women with vasomotor symptoms.
    Gaudard AM; Silva de Souza S; Puga ME; Marjoribanks J; da Silva EM; Torloni MR
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010407. PubMed ID: 27479272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for women with polycystic ovary syndrome not actively trying to conceive.
    Xiong T; Fraison E; Kolibianaki E; Costello MF; Venetis C; Kostova EB
    Cochrane Database Syst Rev; 2023 Jul; 7(7):CD008565. PubMed ID: 37462232
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral contraceptive pill, progestogen or oestrogen pretreatment for ovarian stimulation protocols for women undergoing assisted reproductive techniques.
    Farquhar C; Rombauts L; Kremer JA; Lethaby A; Ayeleke RO
    Cochrane Database Syst Rev; 2017 May; 5(5):CD006109. PubMed ID: 28540977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progestogens or progestogen-releasing intrauterine systems for uterine fibroids (other than preoperative medical therapy).
    Sangkomkamhang US; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2020 Nov; 11(11):CD008994. PubMed ID: 33226133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.